Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
| ▸ | PREP | P48147 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2789326 | 0.77 | AKR1C3 (0.49) | HPGDSMN1; SMN2AKR1C3KDM4E | |
| SCHEMBL7893346 | 0.73 | PROKR1 (0.43) | HPGDSMN1; SMN2ALDH1A1MAPK1KDM4E | |
| SCHEMBL8215188 | 0.70 | ADAM17 (0.40) | AKR1C3 | |
| SCHEMBL14452407 | 0.70 | ADAM17 (0.40) | AKR1C3 | |
| SCHEMBL13605836 | 0.70 | ADAM17 (0.40) | AKR1C3 | |
| SCHEMBL7899970 | 0.70 | HPGDS (0.51) | HPGDAKR1C3ALDH1A1KDM4E | |
| SCHEMBL2789436 | 0.70 | HPGDS (0.51) | HPGDAKR1C3ALDH1A1KDM4E | |
| SCHEMBL2819315 | 0.69 | CYP51A1 (0.37) | HPGDSMN1; SMN2ALDH1A1GRIN2B | |
| SCHEMBL27367437 | 0.68 | DRD2 (0.52) | AKR1C3KDM4E | |
| SCHEMBL6067790 | 0.68 | HPGD (0.61) | HPGDSMN1; SMN2ALDH1A1MAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010111634-A2 | RENIN INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-09-30 | — | — | WO | disclosed |